Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Toronto Dominion Bank
TD
$200B
| $17.2M | 0.01% |
277,497
-4,438
| -2% | -$267K |
|
|
EXAS
777
DELISTED
Exact Sciences
EXAS
| $17.2M | 0.01% |
182,844
-18,241
| -9% | -$1.42M |
|
778
Equitable Holdings
EQH
$14.1B
| $17.1M | 0.01% |
628,532
-26,594
| -4% | -$673K |
|
779
TripAdvisor
TRIP
$1.26B
| $17M | 0.01% |
1,033,942
+302,211
| +41% | +$5.12M |
|
780
Federal Realty Investment Trust
FRT
$10.3B
| $17M | 0.01% |
175,737
+125,850
| +252% | +$11.8M |
|
781
iShares Biotechnology ETF
IBB
$9.77B
| $17M | 0.01% |
133,885
-18,156
| -12% | -$2.36M |
|
782
CALL
Archer Daniels Midland
ADM
$36.9B
| $17M | 0.01% |
+224,500
| New | +$17M |
|
783
SM Energy
SM
$6.87B
| $16.9M | 0.01% |
534,599
+26,744
| +5% | +$756K |
|
784
Macy's
M
$6.68B
| $16.9M | 0.01% |
1,052,600
+102,873
| +11% | +$1.65M |
|
|
FLG
785
Flagstar Bank National Association
FLG
$5.82B
| $16.9M | 0.01% |
500,833
-43,024
| -8% | -$1.31M |
|
786
DoubleVerify
DV
$2.03B
| $16.9M | 0.01% |
433,698
+429,134
| +9,403% | +$13.8M |
|
787
United Microelectronic
UMC
$46.9B
| $16.9M | 0.01% |
2,135,830
+1,467,019
| +219% | +$12.1M |
|
788
Envista
NVST
$4.52B
| $16.8M | 0.01% |
495,391
+328,231
| +196% | +$11.6M |
|
789
Bio-Rad Laboratories Class A
BIO
$9.42B
| $16.7M | 0.01% |
43,960
+20,554
| +88% | +$8.36M |
|
790
PUT
Rapid7
RPD
$773M
| $16.7M | 0.01% |
368,000
-48,600
| -12% | -$2.25M |
|
791
Albertsons Companies
ACI
$5.83B
| $16.6M | 0.01% |
759,392
+430,237
| +131% | +$8.95M |
|
792
Regency Centers
REG
$14.1B
| $16.5M | 0.01% |
267,689
+199,776
| +294% | +$11.9M |
|
793
Royal Bank of Canada
RY
$293B
| $16.5M | 0.01% |
172,681
-57,748
| -25% | -$5.51M |
|
794
PUT
Biogen
BIIB
$30.7B
| $16.5M | 0.01% |
57,800
+36,400
| +170% | +$10.8M |
|
795
Generac Holdings
GNRC
$12.5B
| $16.5M | 0.01% |
110,326
+58,170
| +112% | +$6.63M |
|
796
Portland General Electric
POR
$5.77B
| $16.3M | 0.01% |
349,116
-39,954
| -10% | -$1.98M |
|
|
GOOS
797
Canada Goose Holdings
GOOS
$856M
| $16.3M | 0.01% |
917,271
+67,387
| +8% | +$1.21M |
|
798
Knight Transportation
KNX
$11.4B
| $16.3M | 0.01% |
293,005
+106,655
| +57% | +$5.95M |
|
799
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.4B
| $16.2M | 0.01% |
+832,416
| New | +$15.9M |
|
800
Campbell Soup
CPB
$6.87B
| $16.2M | 0.01% |
354,260
+141,138
| +66% | +$7.28M |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.